"Pinehurst Medical Clinic Cardiology - Sanford is conveniently located at 110 Fields Drive, Sanford, North Carolina. The cardiology team consists of physicians, interventional cardiologists, and nurse practitioners committed to improving their patients' heart health. Treating more than 20,000 patients annually, Pinehurst Medical Clinic cardiology providers offer a broad range of comprehensive cardiology services in state-of-the-art facilities utilizing the most up-to-date medical technology. Services can include echocardiograms, heart catheterizations, and pacemaker analysis. Pinehurst Medical Clinic Cardiology - Sanford cares for your heart health needs, Monday - Thursday from 8 a.m. - 4:30 p.m. and Friday from 8 a.m. - 2 p.m."

During the past decade, Sanford Cardiology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Cardiology" #1 sponsor was "Brigham and Women's Hospital" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Cardiology" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Cardiology" are "Cardiovascular Disease" (2 trials), "ASCVD" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "High Cardiovascular Risk" (1 trials). Many other conditions were trialed in "Sanford Cardiology" in a lesser frequency.

Most popular intervention types in "Sanford Cardiology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials), "Lorcaserin hydrochloride" (1 trials) and "Methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Cardiology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Sanford Cardiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Sanford Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".